Polycystic Ovary Syndrome and Risk of Type 2 Diabetes, Coronary Heart Disease, and Stroke
The DOI matches its Crossref record; 49 of the 53 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) has been associated with diabetes and cardiovascular disease; however, whether the relationship is causal is uncertain. We conducted a two-sample Mendelian randomization study to investigate the associations of PCOS with type 2 diabetes, coronary heart disease (CHD), and stroke. Association between PCOS and diabetes risk was examined in European and Asian cohorts, both sex specific and sex combined. Causal effects of PCOS on risks of CHD and stroke were evaluated in European cohorts. Stroke was analyzed as any stroke as well as four subtypes of stroke (ischemic, large artery, cardioembolic, small vessel). We found no association of genetically predicted PCOS with risk of diabetes, CHD, or stroke. This suggests that PCOS in and of itself does not increase the risk of these outcomes. Other features of PCOS (obesity, elevated testosterone, low sex hormone binding globulin) may explain the association between PCOS and cardiometabolic diseases. In light of these results, efforts to prevent cardiometabolic complications in PCOS should focus on women with high-risk features rather than all women with PCOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity, insulin resistance, and dyslipidemia are common clinical features in women with PCOS and increase the risk for cardiometabolic diseases and reproductive cancers by ≥50% [3]”
From Availability and Use of Digital Technology Among Women With Polycystic Ovary Syndrome: Scoping Review (2025) · cites this paper as [3]
Citations
Cites
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816 · cited 6×
“In all cases, the MR-Egger intercepts were not different from zero, indicating absence of directional pleiotropy.”
BackgroundMethodInfluentialBowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922 · cited 2×
“The weighted median approach can provide a consistent causal effect estimate as long as at least 50% of the information contributing to the analysis comes from valid instrumental variables (20).”
BackgroundMethodThe MR-Base platform supports systematic causal inference across the human phenome
Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959 · cited 2×
“We used R 3.6.3 software and the R package TwoSampleMR (22) for the analyses.”
MethodInfluentialBurgess, S., Bowden, J., Fall, T., Ingelsson, E., & Thompson, S. G. (2017) · Epidemiology · doi:10.1097/ede.0000000000000559 · Cited by 2,017
A framework for the investigation of pleiotropy in two‐sample summary data Mendelian randomization
Bowden, J., Del Greco M, F., Minelli, C., Davey Smith, G., Sheehan, N., & Thompson, J. (2017) · Statistics in Medicine · doi:10.1002/sim.7221 · Cited by 1,887 · cited 1×
“Primary MR analyses were conducted with the inverse variance weighted (IVW) method with random effects (18).”
MethodMahajan, A., Taliun, D., Thurner, M., Robertson, N. R., Torres, J. M., Rayner, N. W., Payne, A. J., Steinthorsdottir, V., Scott, R. A., Grarup, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0241-6 · Cited by 1,744
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743 · cited 1×
“However, some studies that did attempt to match for or statistically adjust for BMI reported positive association between PCOS and diabetes (25,31,32).”
ResultMalik, R., Chauhan, G., Traylor, M., Sargurupremraj, M., Okada, Y., Mishra, A., Rutten-Jacobs, L., Giese, A.-K., van der Laan, S. W., Gretarsdottir, S., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0058-3 · Cited by 1,599
Bowden, J., Del Greco M., F., Minelli, C., Davey Smith, G., Sheehan, N. A., & Thompson, J. R. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw220 · Cited by 1,565
Pulit, S. L., Stoneman, C., Morris, A. P., Wood, A. R., Glastonbury, C. A., Tyrrell, J., Yengo, L., Ferreira, T., Marouli, E., Ji, Y., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddy327 · Cited by 1,163
Cited by
Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., & Piltonen, T. T. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00511-3 · Cited by 495
“However, another Mendelian randomization analysis did not find a causal role for PCOS in T2DM, coronary heart disease or stroke, suggesting that PCOS and cardiometabolic disease share common underpinnings (for example, obesity) rather than a causal relationship 91 .”
Self-citationDeconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification
Dapas, M., & Dunaif, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac001 · Cited by 300
Polycystic ovary syndrome as a metabolic disease
Helvaci, N., & Yildiz, B. O. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01057-w · Cited by 188
Polycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular disease
Guan, C., Zahid, S., Minhas, A. S., Ouyang, P., Vaught, A., Baker, V. L., & Michos, E. D. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.03.009 · Cited by 188
Heidarzadehpilehrood, R., Pirhoushiaran, M., Abdollahzadeh, R., Osman, M. B., Sakinah, M., Nordin, N., & Hamid, H. A. (2022) · Genes · doi:10.3390/genes13020302 · Cited by 152
“The most important risk factors for this cancer include polycystic ovary syndrome, diabetes, and obesity [104].”
Background
Metadata
- Authors
- Zhu, T., Cui, J., & Goodarzi, M. O.
- Affiliations
- Cedars-Sinai Medical Center (US)
- Corresponding author
- Goodarzi, Mark O.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2020-11-06
- Volume
- 70
- Issue
- 2
- Pages
- 627-637
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W3095084496
- Cited by
- 226
- References
- 53
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 36 · 2023: 83 · 2022: 29 · 2021: 13
- FWCI
- 27.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- polycystic ovary syndrome, type 2 diabetes, coronary artery disease, stroke, cardiometabolic disease, causal inference, genetic risk prediction, sex differences, stroke subtypes, obesity, testosterone, sex hormone-binding globulin
- MeSH terms
- Adult, Coronary Disease, Diabetes Mellitus, Type 2, Female, Humans, Polycystic Ovary Syndrome, Risk, Comorbidity, Case-Control Studies, Stroke, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Polycystic Ovary Syndrome and Risk of Type 2 Diabetes, Coronary Heart Disease, and Stroke. https://app.cochat.ai/papers/10.2337/db20-0800
- The paper
- Zhu, T., Cui, J., & Goodarzi, M. O. (2021). Polycystic Ovary Syndrome and Risk of Type 2 Diabetes, Coronary Heart Disease, and Stroke. Diabetes. https://doi.org/10.2337/db20-0800
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.